<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><data_sharing_plan>IPD Sharing (as of November 2021): No</data_sharing_plan><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2396235</full_dataset_link><location>China</location><study_start_month>1</study_start_month><keyword>Pretreated</keyword><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer</name><description>This include two parts, part 1 is a dose optimizing study and part 2 is a randomized, controlled study.</description><dates><creation>2022-01-15</creation></dates><accession>2396235</accession><cross_references><ClinicalTrials___gov>NCT05130021</ClinicalTrials___gov></cross_references></HashMap>